Algorae Pharmaceuticals (ASX: 1AI) has completed the prediction-generation phase of a multi-anchor drug combination program using AlgoraeOS v2 (AOS2) to…
Browsing: Biotechnology
Vertex Pharmaceuticals stock is back in focus after fresh interim data from the RUBY-3 kidney disease trial and ongoing attention…
NextCure has recently drawn attention with new data around its immuno-oncology pipeline and a collaboration with Eli Lilly, while the…
Event Programs For quick viewing, C-SPAN provides Points of Interest markers for some events. Short Takes Taken from C-SPAN’s gavel-to-gavel…
Seres Therapeutics has reported its first-quarter 2026 results and updated investors on the commercialization of its microbiome therapy Vowst in…
Biotechnology has traditionally been a field that demands patience. Experiments often require repeated manual steps, careful sample preparation, and long…
Biotechnology is often associated with breakthrough moments — a new therapy, a scientific discovery, or a revolutionary medical technology. Headlines…
Sana Biotechnology, Inc SEATTLE , May 15, 2026 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on…
Austin-based Austin-based biotechnology company Natera was valued at roughly $28.4 billion as of Thursday, more even than the $21.5 billion…
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported a net loss attributable to common stockholders of $1.94M for the first quarter of 2026,…